Anti-CD20 antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7422739
APP PUB NO 20020197255A1
SERIAL NO

09911703

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are chimeric, immunologically active, isolated, and radiolabeled antibodies directed against the CD20 antigen. The antibodies are useful for treating and diagnosing B cell disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOGEN, INC.;IDEC PHARMACEUTICALS CORP. (DELAWARE)

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, Darrell R Escondido, CA 26 1830
Hanna, Nabil Rancho Santa Fe, CA 92 3704
Newman, Roland A San Diego, CA 24 2428
Rastetter, William H Rancho Santa Fe, CA 25 1894
Reff, Mitchell E San Diego, CA 35 2137

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation